Sartorius Stedim Biotech (OTCMKTS:SDMHF) Stock Price Down 0.1% – Time to Sell?

Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF)’s stock price fell 0.1% during trading on Thursday . The stock traded as low as $259.50 and last traded at $259.50. 100 shares were traded during mid-day trading, a decline of 96% from the average session volume of 2,633 shares. The stock had previously closed at $259.65.

Analysts Set New Price Targets

Separately, Barclays reiterated an “overweight” rating on shares of Sartorius Stedim Biotech in a research note on Tuesday. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Sartorius Stedim Biotech Stock Down 0.1%

The business’s 50 day moving average is $238.38 and its 200-day moving average is $224.92.

Sartorius Stedim Biotech Company Profile

Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell‐ and gene‐based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.

Key product offerings include single‐use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.